150 related articles for article (PubMed ID: 38215354)
1. Streptococcus salivarius K12 Alleviates Oral Mucositis in Patients Undergoing Radiotherapy for Malignant Head and Neck Tumors: A Randomized Controlled Trial.
Peng X; Li Z; Pei Y; Zheng S; Liu J; Wang J; Li R; Xu X
J Clin Oncol; 2024 Apr; 42(12):1426-1435. PubMed ID: 38215354
[TBL] [Abstract][Full Text] [Related]
2. Phase IIb, Randomized, Double-Blind Trial of GC4419 Versus Placebo to Reduce Severe Oral Mucositis Due to Concurrent Radiotherapy and Cisplatin For Head and Neck Cancer.
Anderson CM; Lee CM; Saunders DP; Curtis A; Dunlap N; Nangia C; Lee AS; Gordon SM; Kovoor P; Arevalo-Araujo R; Bar-Ad V; Peddada A; Colvett K; Miller D; Jain AK; Wheeler J; Blakaj D; Bonomi M; Agarwala SS; Garg M; Worden F; Holmlund J; Brill JM; Downs M; Sonis ST; Katz S; Buatti JM
J Clin Oncol; 2019 Dec; 37(34):3256-3265. PubMed ID: 31618127
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of the probiotic Streptococcus salivarius K12 for the treatment and/or prevention of sore throat: a systematic review.
Wilcox CR; Stuart B; Leaver H; Lown M; Willcox M; Moore M; Little P
Clin Microbiol Infect; 2019 Jun; 25(6):673-680. PubMed ID: 30616011
[TBL] [Abstract][Full Text] [Related]
4. Preliminary data revealing efficacy of
La Torre F; Sota J; Insalaco A; Conti G; Del Giudice E; Lubrano R; Breda L; Maggio MC; Civino A; Mastrorilli V; Loconte R; Natale MF; Celani C; Romeo M; Patroniti S; Gentile C; Vitale A; Caggiano V; Gaggiano C; Diomeda F; Cattalini M; Lopalco G; Emmi G; Parronchi P; Gentileschi S; Cardinale F; Aragona E; Shahram F; Marino A; Barone P; Moscheo C; Ozkiziltas B; Carubbi F; Alahmed O; Iezzi L; Ogunjimi B; Mauro A; Tarsia M; Mahmoud AAA; Giardini HAM; Sfikakis PP; Laskari K; Więsik-Szewczyk E; Hernández-Rodríguez J; Frediani B; Gómez-Caverzaschi V; Tufan A; Almaghlouth IA; Balistreri A; Ragab G; Fabiani C; Cantarini L; Rigante D
Front Med (Lausanne); 2023; 10():1105605. PubMed ID: 36873863
[TBL] [Abstract][Full Text] [Related]
5. Randomized placebo-controlled phase II trial of high-dose melatonin mucoadhesive oral gel for the prevention and treatment of oral mucositis in patients with head and neck cancer undergoing radiation therapy concurrent with systemic treatment.
Lozano A; Marruecos J; Rubió J; Farré N; Gómez-Millán J; Morera R; Planas I; Lanzuela M; Vázquez-Masedo MG; Cascallar L; Giralt J; Escames G; Valentí V; Grima P; Bosser R; Tarragó C; Mesía R
Clin Transl Oncol; 2021 Sep; 23(9):1801-1810. PubMed ID: 33738704
[TBL] [Abstract][Full Text] [Related]
6. Effect of Selenium on Incidence and Severity of Mucositis during Radiotherapy in Patients with Head and Neck Cancer.
Laali E; Manifar S; Kazemian A; Jahangard-Rafsanjani Z; Gholami K
Oral Health Prev Dent; 2020 Sep; 18(4):765-771. PubMed ID: 32895660
[TBL] [Abstract][Full Text] [Related]
7. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
Akova M; Unal S
Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
[TBL] [Abstract][Full Text] [Related]
8. Randomized double-blind, placebo-controlled trial evaluating oral glutamine on radiation-induced oral mucositis and dermatitis in head and neck cancer patients.
Huang CJ; Huang MY; Fang PT; Chen F; Wang YT; Chen CH; Yuan SS; Huang CM; Luo KH; Chuang HY; Wang YY; Lee HH
Am J Clin Nutr; 2019 Mar; 109(3):606-614. PubMed ID: 30753262
[TBL] [Abstract][Full Text] [Related]
9. Reduction of group A beta-hemolytic streptococcus pharyngo-tonsillar infections associated with use of the oral probiotic Streptococcus salivarius K12: a retrospective observational study.
Gregori G; Righi O; Risso P; Boiardi G; Demuru G; Ferzetti A; Galli A; Ghisoni M; Lenzini S; Marenghi C; Mura C; Sacchetti R; Suzzani L
Ther Clin Risk Manag; 2016; 12():87-92. PubMed ID: 26855579
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of Dentoxol® in the prevention of radiation-induced oral mucositis in head and neck cancer patients (ESDOM): a randomized, multicenter, double-blind, placebo-controlled, phase II trial.
Lalla RV; Solé S; Becerra S; Carvajal C; Bettoli P; Letelier H; Santini A; Vargas L; Cifuentes A; Larsen F; Jara N; Oyarzún J; Feinn R; Bustamante E; Martínez B; Rosenberg D; Galván T
Support Care Cancer; 2020 Dec; 28(12):5871-5879. PubMed ID: 32266567
[TBL] [Abstract][Full Text] [Related]
11. Palifermin reduces severe mucositis in definitive chemoradiotherapy of locally advanced head and neck cancer: a randomized, placebo-controlled study.
Le QT; Kim HE; Schneider CJ; Muraközy G; Skladowski K; Reinisch S; Chen Y; Hickey M; Mo M; Chen MG; Berger D; Lizambri R; Henke M
J Clin Oncol; 2011 Jul; 29(20):2808-14. PubMed ID: 21670453
[TBL] [Abstract][Full Text] [Related]
12. Palifermin decreases severe oral mucositis of patients undergoing postoperative radiochemotherapy for head and neck cancer: a randomized, placebo-controlled trial.
Henke M; Alfonsi M; Foa P; Giralt J; Bardet E; Cerezo L; Salzwimmer M; Lizambri R; Emmerson L; Chen MG; Berger D
J Clin Oncol; 2011 Jul; 29(20):2815-20. PubMed ID: 21670447
[TBL] [Abstract][Full Text] [Related]
13. A multinational, randomized phase III trial of iseganan HCl oral solution for reducing the severity of oral mucositis in patients receiving radiotherapy for head-and-neck malignancy.
Trotti A; Garden A; Warde P; Symonds P; Langer C; Redman R; Pajak TF; Fleming TR; Henke M; Bourhis J; Rosenthal DI; Junor E; Cmelak A; Sheehan F; Pulliam J; Devitt-Risse P; Fuchs H; Chambers M; O'Sullivan B; Ang KK
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):674-81. PubMed ID: 14967419
[TBL] [Abstract][Full Text] [Related]
14. Interferon Inhibition for Lupus with Anifrolumab: Critical Appraisal of the Evidence Leading to FDA Approval.
Loncharich MF; Anderson CW
ACR Open Rheumatol; 2022 Jun; 4(6):486-491. PubMed ID: 35157371
[TBL] [Abstract][Full Text] [Related]
15. Randomized Phase 2 Trial of a Novel Clonidine Mucoadhesive Buccal Tablet for the Amelioration of Oral Mucositis in Patients Treated With Concomitant Chemoradiation Therapy for Head and Neck Cancer.
Giralt J; Tao Y; Kortmann RD; Zasadny X; Contreras-Martinez J; Ceruse P; Arias de la Vega F; Lalla RV; Ozsahin EM; Pajkos G; Mazar A; Attali P; Bossi P; Vasseur B; Sonis S; Henke M; Bensadoun RJ
Int J Radiat Oncol Biol Phys; 2020 Feb; 106(2):320-328. PubMed ID: 31669562
[TBL] [Abstract][Full Text] [Related]
16. Effects of Streptococcus salivarius K12 with nystatin on oral candidiasis-RCT.
Hu L; Mao Q; Zhou P; Lv X; Hua H; Yan Z
Oral Dis; 2019 Sep; 25(6):1573-1580. PubMed ID: 31177581
[TBL] [Abstract][Full Text] [Related]
17. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
18. Preventive effect and safety of Chinese herbal medicine for oral mucositis during radiotherapy in patients with head and neck cancer: Study protocol for a randomized trial.
Cheng YC; Wang YM; Lin YH; Cheng JY; Li SH; Huang YC; Tsai MY
Contemp Clin Trials Commun; 2022 Jun; 27():100912. PubMed ID: 35345874
[TBL] [Abstract][Full Text] [Related]
19. Randomized double-blind placebo-controlled trial of celecoxib for oral mucositis in patients receiving radiation therapy for head and neck cancer.
Lalla RV; Choquette LE; Curley KF; Dowsett RJ; Feinn RS; Hegde UP; Pilbeam CC; Salner AL; Sonis ST; Peterson DE
Oral Oncol; 2014 Nov; 50(11):1098-103. PubMed ID: 25151488
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of propolis mouthwash in management of radiotherapy induced oral mucositis; A randomized, double blind clinical trial.
Dastan F; Ameri A; Dodge S; Hamidi Shishvan H; Pirsalehi A; Abbasinazari M
Rep Pract Oncol Radiother; 2020; 25(6):969-973. PubMed ID: 33100913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
